Small Cap Feast
Small Cap Feast – 11th April 2017
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 966
Total number of AIM Companies trading: 942*
* As at 10 April 2017
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 84*
Total number of NEX Growth Market Companies trading: 81*
* As at 10 April 2017
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): *
Total number of Standard List Companies trading: *
* As at 10 April 2017
Dish of the Day:
First day of dealings from K3 Capital Group, the business and company sales specialist in the UK Franchise Brands has completed the RTO of Metro Rod raising £20m. At 67p
First day of dealings from K3 Capital Group, the business and company sales specialist in the UK
Franchise Brands has completed the RTO of Metro Rod raising £20m. At 67p
Off the Menu:
No AIM Leavers today
No AIM Leavers today
Dish of the Day:
No NEX Growth Market Joiners Today
No NEX Growth Market Joiners Today
Off the Menu:
No NEX Growth Market Leavers Today
No NEX Growth Market Leavers Today
What’s Cooking in the IPO Kitchen?
Eddie Stobart Logistics— Schedule 1. Admission expected 25 April but capital raising details TBC.
ADES International Holding— Intends to join the Standard List in May raising up to $170m plus a vendor sale. Provider of offshore and onshore oil and gas drilling and production services in the Middle East and Africa. Admission expected in May.
Schedule One from Lakehouse – an asset and energy support services group that constructs, improves, maintains and provides services to homes, schools, public and commercial buildings. Admission expected 11 May. Expected market cap £74m.
Tufton Oceanic Assets– Offer extended to 9 May to enable investors to complete further due diligence.
Fitbug Holdings* (FITB.L) 0.12p £1.99m
The digital wellness provider for corporate organisations, now trading as Kin Wellness, has announced a customer renewal for wellbeing services with a large financial institution.
After a successful first year, the client has renewed its arrangements with the Company’s strategic partner, for the same group of employees as the previous year. This is expected to generate around £70,000 of service revenues for the Group during 2017.
Client confidentiality does not allow for the disclosure of further details at this time.
Defenx (DFX.L) 107p £9.22m
FYDec16 results from the mobile security software solutions company. 5th yr of profitable growth. Revenue +58% to €7.09m. 88% growth in op profits (before transaction costs) to €1.84m. Defenx separately announced acquisition of bespoke version of BV-Tech’s encrypted voice & messaging software for €2.65m in shares. BV Tech investing €1.15m at 114p bringing holding to 24.8%. Strategic partnership. “Defenx is on track to launch new products, enter new markets and broaden its management team in 2017. The board of Defenx is confident that the Group will show continued growth in revenue and profit over the coming year in the ever-exciting security software market. I firmly believe that our long-term partnership with BV-Tech, announced today, will generate high quality, recurring revenues in the medium term. “ FY17E PE <5x
Valiant Investments (NEX:VALP) 0.285p £2.8m
Valiant has raised GBP47,750 by way of a placing of 47,750,000 new ordinary shares at a price of 0.1p per share. The monies raised will provide the Company with additional working capital and enable it to further accelerate the development of its 84.7% owned subsidiary, Flamethrower plc.
Digital Barriers (DGB.L) 27p £44.59m
The specialist provider of visually intelligent solutions to the global surveillance, security and safety markets, has secured a contract for its facial recognition technology with Careem: the leading ride-hailing provider in the Middle East and North Africa. The contract award follows a competitive benchmarking process and is one of a number of framework contracts that were in the final stages of contract negotiation at the time of the Group’s trading update on 24 March. Once the software has been deployed, the contract will deliver recurring software revenue to the Group up and until the end of calendar year 2018, with an option thereafter to extend. The smartphone solution will ensure that the actual driver of a given vehicle can be matched in real-time to the authorised and accredited driver of that vehicle. FYMar17E £33.1m rev, £6m loss.
Zinc Media (ZIN.L) 1.2p £7.44m
The TV and multimedia content producer has appointed award winning executive producer, Roy Ackerman, as Managing Director of Films of Record and Director of International Strategy, TV. The new appointment is in line with Zinc Media’s strategy of expanding its presence within the US and wider global TV markets. Roy’s latest role was as Managing Director at Pulse Films, where he rapidly rebooted its TV division with a slate of big commissions. Prior to that he led the transformation of Jamie Oliver’s Fresh One Productions from a celebrity vehicle into a global multi-genre independent, creating award-winning content in commercials, drama, factual formats and documentaries.
1PM (OPM.L) 58.5p £32.11m
The independent specialist provider of finance facilities to the SME sector has today acquired Bell Finance Limited. Established in 2000, it is a successful, independent, specialist provider of funding for business-critical equipment, primarily “hard” assets comprising plant, machinery and vehicles, for Construction, Recycling and Manufacturing. In addition, Bell provides “Caterham” branded finance for kit cars. The Company is originating approximately £6.0m of new business a year, the majority of which it funds on its own balance sheet, with approximately 15% of deals brokered-on. Consideration up to £3.4m. For FYNov16 Bell had revenue of £1.7m, PBT £0.4m. FYMay17E £16.5m rev and £4.3mPBT.
Draper Esprit (GROW.L) 349p £142.2m
FYMar17 trading update from venture capital firm involved in the creation, funding and development of high-growth digital technology businesses. The Directors anticipate that the gross primary portfolio value of the investment portfolio will be in excess of £112m (30 September 2016: £106.9m, at Admission £78.7m). Excluding new investments and realisations across the portfolio of companies, the gross portfolio value has increased 41% since Admission and 10% over the six month period since 30 September 2016. Following the acquisition of Elderstreet VCT, the announced £20m VCT and EIS fund raisings are progressing ahead of management expectations. Considering further funding.
Kodal Minerals (KOD.L) 0.32p £17.24m
Update on the 5,000m exploration drilling programme in progress focussed on four priority prospects at the Company’s Bougouni Lithium Project in Southern Mali. Substantial pegmatite intersections achieved at three previously undrilled prospects at Bougouni. All three prospects are currently unconstrained vertically or along strike. Infill and extension drilling underway at the previously drilled Ngouanala prospect. Following its recent £500,000 investment, proposed off-take partner Suay Chin has substantially completed its due diligence review to support the potential further investment into the Company of up to £4.3m.
Integumen (SKIN.L) 4.13p £6.8m
The personal health care Company developing and commercialising technology and products for the human integumentary system has signed a strategic supply agreement for an initial term of three years with Mono Dent in South Korea for its oral hygiene products, which will establish an additional income stream from this new market. Opening orders have been received for the TS1 professional product. As part of the exclusive agreement, Mono Dent has committed to a sales and marketing strategy for TS1 to penetrate further the South Korean market. South Korea has approximately 20,000 dental surgeries and is a growing market driven by medical tourism and cosmetic dental surgery.
Immedia Group (IME.L) 33.5p £4.88m
FYDec16 results from the multi-media content and digital solutions provider to global businesses and organisations. Included significant client wins which will benefit 2017 and substantial acquisition of AVC Media Enterprises Ltd in September 2016; funded solely from the Group’s own cash resources. Integration costs contributed to EBITDA reduction. Revenue £2.6m vs £2.4m. EBITDA loss of £83k. “Since the year end we have already seen the anticipated benefits of the AVC acquisition coming through, both in terms of revenue from its own clients and additional services that can be integrated into the Company’s product and service offering to Immedia’s existing clients, and we expect that to continue and develop over the course of the year.”
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.